Back to Search Start Over

Iron-Reduced Graphene Oxide Core-Shell Micromotors Designed for Magnetic Guidance and Photothermal Therapy under Second Near-Infrared Light.

Authors :
Donoso-González O
Riveros AL
Marco JF
Venegas-Yazigi D
Paredes-García V
Olguín CF
Mayorga-Lobos C
Lobos-González L
Franco-Campos F
Wang J
Kogan MJ
Bollo S
Yañez C
Báez DF
Source :
Pharmaceutics [Pharmaceutics] 2024 Jun 25; Vol. 16 (7). Date of Electronic Publication: 2024 Jun 25.
Publication Year :
2024

Abstract

Core-shell micro/nanomotors have garnered significant interest in biomedicine owing to their versatile task-performing capabilities. However, their effectiveness for photothermal therapy (PTT) still faces challenges because of their poor tumor accumulation, lower light-to-heat conversion, and due to the limited penetration of near-infrared (NIR) light. In this study, we present a novel core-shell micromotor that combines magnetic and photothermal properties. It is synthesized via the template-assisted electrodeposition of iron (Fe) and reduced graphene oxide (rGO) on a microtubular pore-shaped membrane. The resulting Fe-rGO micromotor consists of a core of oval-shaped zero-valent iron nanoparticles with large magnetization. At the same time, the outer layer has a uniform reduced graphene oxide (rGO) topography. Combined, these Fe-rGO core-shell micromotors respond to magnetic forces and near-infrared (NIR) light (1064 nm), achieving a remarkable photothermal conversion efficiency of 78% at a concentration of 434 µg mL <superscript>-1</superscript> . They can also carry doxorubicin (DOX) and rapidly release it upon NIR irradiation. Additionally, preliminary results regarding the biocompatibility of these micromotors through in vitro tests on a 3D breast cancer model demonstrate low cytotoxicity and strong accumulation. These promising results suggest that such Fe-rGO core-shell micromotors could hold great potential for combined photothermal therapy.<br />Competing Interests: The authors declare no conflicts of interest.

Details

Language :
English
ISSN :
1999-4923
Volume :
16
Issue :
7
Database :
MEDLINE
Journal :
Pharmaceutics
Publication Type :
Academic Journal
Accession number :
39065553
Full Text :
https://doi.org/10.3390/pharmaceutics16070856